Key result
Pre-operative chemotherapy using doxorubicin, cisplatin, and ifosfamide resulted in significant tumor shrinkage of a huge mesenteric liposarcoma, allowing for a margin-negative surgical resection.
Population
1 patient with a huge ileocolonic mesenteric liposarcoma
Design
Case_report
Authors
Loading...
May support neoadjuvant chemotherapy for unresectable mesenteric liposarcoma; hypothesis-generating case report requiring prospective validation.
Case Report (n=1)
Pre-operative chemotherapy with doxorubicin, cisplatin, and ifosfamide may enable complete surgical resection of large mesenteric liposarcomas by inducing significant tumor shrinkage.
Ishiguro et al. (2006) conducted a case report in Huge ileocolonic mesenteric liposarcoma (n=1). Pre-operative chemotherapy using doxorubicin, cisplatin and ifosfamide was evaluated on Tumor shrinkage and surgical resection margin. Pre-operative chemotherapy using doxorubicin, cisplatin, and ifosfamide resulted in significant tumor shrinkage of a huge mesenteric liposarcoma, allowing for a margin-negative surgical resection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: